INVOLVEMENT OF GRB2 ADAPTOR PROTEIN IN NUCLEOPHOSMIN-ANAPLASTIC LYMPHOMA KINASE (NPM-ALK) MEDIATED SIGNALING AND ANAPLASTIC LARGE CELL LYMPHOMA GROWTH

被引：0
|
作者：
Riera, L. [1 ]
Lasorsa, E. [1 ]
Ambrogio, C. [1 ]
Surrenti, N. [1 ]
Voena, C. [1 ]
Chiarle, R. [1 ]
机构：
[1] Univ Turin, Turin, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0414
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [41] NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
    Murga-Zamalloa, C. A.
    Mendoza-Reinoso, V.
    Sahasrabuddhe, A. A.
    Rolland, D.
    Hwang, S. R.
    McDonnell, S. R. P.
    Sciallis, A. P.
    Wilcox, R. A.
    Bashur, V.
    Elenitoba-Johnson, K.
    Lim, M. S.
    ONCOGENE, 2017, 36 (15) : 2085 - 2094
  • [42] The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma
    Ladanyi, M
    CANCER SURVEYS, 1997, 30 : 59 - 75
  • [43] NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a
    Gu, TL
    Tothova, Z
    Scheijen, B
    Griffin, JD
    Gilliland, DG
    Sternberg, DW
    BLOOD, 2004, 103 (12) : 4622 - 4629
  • [44] NPM-ALK expression levels are associated to different miRNA profiles in paediatric anaplastic large cell lymphoma
    Garbin, Anna
    Lovisa, Federica
    Basso, Katia
    Holmes, Antony B.
    Carraro, Elisa
    Pizzi, Marco
    Garaventa, Alberto
    Tondo, Annalisa
    Mura, Rossella
    Buffardi, Salvatore
    Basso, Giuseppe
    D'Amore, Emanuele S. G.
    Pillon, Marta
    Mussolin, Lara
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 42 - 42
  • [45] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
    Haque, Moinul
    Li, Jing
    Huang, Yung-Hsing
    Almowaled, Meaad
    Barger, Carter J.
    Karpf, Adam R.
    Wang, Peng
    Chen, Will
    Turner, Suzanne D.
    Lai, Raymond
    CANCERS, 2019, 11 (08)
  • [46] Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma
    Li, Chunmei
    Takino, Hisashi
    Eimoto, Tadaaki
    Ishida, Takashi
    Inagaki, Atsushi
    Ueda, Ryuzo
    Suzuki, Ritsuro
    Yoshino, Tadashi
    Nakagawa, Atsuko
    Nakamura, Shigeo
    Inagaki, Hiroshi
    MODERN PATHOLOGY, 2007, 20 (06) : 648 - 655
  • [47] Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity
    Cussac, D
    Greenland, C
    Roche, S
    Bai, RY
    Duyster, J
    Morris, SW
    Delsol, G
    Allouche, M
    Payrastre, B
    BLOOD, 2004, 103 (04) : 1464 - 1471
  • [48] Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel hsp90-client tyrosine kinase:: Down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK+ CD30+ lymphoma cells by the hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin
    Bonvini, P
    Gastaldi, T
    Falini, B
    Rosolen, A
    CANCER RESEARCH, 2002, 62 (05) : 1559 - 1566
  • [49] A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
    Trinei, M
    Lanfrancone, L
    Campo, E
    Pulford, K
    Mason, DY
    Pelicci, PG
    Falini, B
    CANCER RESEARCH, 2000, 60 (04) : 793 - 798
  • [50] STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
    Wu, Chengsheng
    Molavi, Ommoleila
    Zhang, Haifeng
    Gupta, Nidhi
    Alshareef, Abdulraheem
    Bone, Kathleen M.
    Gopal, Keshav
    Wu, Fang
    Lewis, Jamie T.
    Douglas, Donna N.
    Kneteman, Norman M.
    Lai, Raymond
    BLOOD, 2015, 126 (03) : 336 - 345
12345